Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT02410304
Eligibility Criteria:
* Inclusion Criteria:
* Both gender patients aged 18 -to 80 years old
* Patients will be eligible if they fulfill ACR/EULAR 2010 rheumatoid arthritis
* All the treatment recommended for rheumatoïd arthritis (anti-inflammatory drugs, steroids, hydroxychloroquine, salazopyrine, methotrexate, ARAVA or biologics treatment: Enbrel, humira, remicade, cimzia, tocilizumab, rituximab, abatacept, simponi) would be in stable posology since at least 12 weeks before inclusion
* Patients would be able to understand and be agree with the protocole
* Patients would be able to consent
* Exclusion Criteria:
* Patient unable to cooperate patient and who refuse to sign consent form
* Patient unable to understand the study,under administrative supervision or legal guardianship
* Signs and symptoms of uncontroled or severe progressive pathology at the level of renal, hepatic, hematological, endocrine, lung, cardiac, neurological or cerebral
* Scheduled surgery procedure during the study on the estimated joint.
* Patient non-affiliated to social security
* Pregnant and nursing mothers
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02410304
Study Brief:
Protocol Section:
NCT02410304